Journal of Pediatric Endocrinology & Metabolism

Real-world effectiveness of tirzepatide among youth with type 2 diabetes and/or obesity: a multicenter analysis

By Yllka Valdez, Natalie Segev, Neha Parimi, Risa M. Wolf

Study in peopleInterventions

The paper

Yllka Valdez, Natalie Segev, Neha Parimi, Risa M. Wolf

Johns Hopkins University

Journal of Pediatric Endocrinology & Metabolism, 11 Aug 2026

doi.org/10.1515/jpem-2026-0335 PubMed 42576608

Lancet4 Oct 2026
Retatrutide reduces bodyweight in obesity and type 2 diabetes
The New England Journal of Medicine4 Oct 2026
Survodutide reduces weight in adults with diabetes and obesity
Cell Metabolism8 Oct 2026
A triple-target drug cut body weight by up to 19.7% in a trial
The New England Journal of Medicine4 Oct 2026
Retatrutide reduces weight and pain in adults with obesity